Needham & Company LLC Issues Pessimistic Forecast for NeoGenomics (NASDAQ:NEO) Stock Price
NeoGenomics (NASDAQ:NEO – Get Free Report) had its price objective decreased by research analysts at Needham & Company LLC from $18.00 to $8.50 in a research note issued on Tuesday,Benzinga reports. The brokerage presently has a “buy” rating on the medical research company’s stock. Needham & Company LLC’s target price would indicate a potential upside […]
NeoGenomics (NASDAQ:NEO – Get Free Report) had its price objective decreased by research analysts at Needham & Company LLC from $18.00 to $8.50 in a research note issued on Tuesday,Benzinga reports. The brokerage presently has a “buy” rating on the medical research company’s stock. Needham & Company LLC’s target price would indicate a potential upside […]
